on LR Health & Beauty SE (isin : NO0013149658)
LR Health & Beauty SE Maintains Growth in 2024
LR Health & Beauty SE has sustained its growth trajectory in 2024, reporting sales of EUR 289.2 million, a 4.6% increase from the previous year. This growth was partly driven by the realignment of the career plan and successful launches of new products like the LR ZEITGARD Signature cosmetics line and LR HEALTH MISSION treatment.
The company's EBITDA for 2024 stood at EUR 27.3 million, aligning with forecasts despite one-off effects from career plan changes and bond refinancing. The launch of the LR Aloe Via Magic Power Duo further boosted prospects for 2025, with expectations of EBITDA growth.
CEO Dr Andreas Laabs highlighted strategic initiatives focused on digitalisation and product innovation as key drivers. The company aims to seize growth opportunities in the health and beauty sectors in 2025, projecting stable to moderately rising sales.
R. E.
Copyright © 2025 FinanzWire, all reproduction and representation rights reserved.
Disclaimer: although drawn from the best sources, the information and analyzes disseminated by FinanzWire are provided for informational purposes only and in no way constitute an incentive to take a position on the financial markets.
Click here to consult the press release on which this article is based
See all LR Health & Beauty SE news